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The  "adenovirus-associated  viruses"  (AAV)  1 are  a  newly recognized group 
of small defective DNA viruses  that appear  to replicate  only in ceils infected 
with an adenovirus (1-4). At present, four serological types have been defined, 
all  of which were discovered as contaminants  of laboratory stocks of various 
human  and  simian  adenoviruses;  ~ the  natural  host(s)  of these  viruses  is  un- 
known, but antibodies have been found in humans and monkeysY. ~ The AAV 
have shown no species specificity in their host range in tissue culture, but ap- 
pear to replicate with any adenovirus growing in cell cultures of its natural host. 
The mechanism by which adenovirus infection stimulates AAV replication is 
lmknown, as is the extent to which the abortive AAV replicative cycle can pro- 
gress without adenovirus. It is known that many other DNA and RNA viruses 
cannot be used in place of adenovirus  (2,  3),  nor can adenovirus-free filtrates 
or  cells  transformed  by adenovirus  be  substituted  (3).  This  report  describes 
the  use  of  a  quantitative  immunofluorescent  procedure  for  study  of  some 
parameters  of the interaction between AAV-1 and adenovirus  type 7  (Ad.  7), 
and  the results  of studies  to define  the stage of adenovirus replication  which 
renders  a  cell  competent  to  synthesize  AAV. 
Materials and Methods 
Viruses.--Beeause of the defectiveness of AAV it is not possible to propagate them without 
admixture  with an adenovirus.  However,  for quantitative  and  temporal  studies  of AAV- 
adenovirus interactions  it was necessary to use each component free of the other. The AAV 
component was obtained free of infectious adenovirus by heating stock AAV-Ad. 7 virus pooh 
* This work was partially supported by the Etiology Area of the National Cancer Institute, 
National Institutes of Health. 
:~ Viral Carcinogenesis Branch, National Cancer Institute. 
1  The following abbreviations  are used throughout the text: AAV, adenovirus-assodated 
viruses; CF, complement fixation; FA, fluorescent antibody; HEK, human embryonic kidney; 
AGMK, African green monkey kidney;  BME, Eagle's basal medium No. 2 with penidllin, 
streptomycin,  and glutamine;  FUDR, 5-fluorouradl  deoxyriboside. 
2 Hoggan, M. D., N. R. Blacklow, R. Rafajko,  and W. P. Rowe. Unpublished data. 
a Atchison, R. W. Personal  communication. 
4 Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. Unpublished data. 
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at 56°C for 15 min; this procedure inactivates adenovirus infectivity with mlnlmai inactivation 
of AAV (3). The adenovirus component was a strain of Ad. 7, (E46- (0)), (3) which is free of 
detectable AAV by complement fixation  (CF),  fluorescent antigen induction, and electron 
microscopy. 
IThe strain of AAV-1 studied previously (3) was used in all experiments reported here; the 
virus was grown in human embryonic kidney (HEK)  cells using Ad.  7 as helper. Mixed in- 
fected cultures were harvested when adenovirus cytopathogenicity was complete; the culture 
flasks were frozen and thawed three times, the cells shaken into the fluid, and the material 
distributed into screw-capped vials for storage at  -60°C.  The virus stocks were heated at 
56°C for 15 min immediately before use. AAV infectivity titers (3), after heating, were 106- 
10  v's TCIDs0 per 0.1  ml. 
E46- (0) virus was grown in HEK cells, and titrated in tube cultures of HEK cells observed 
for 21 days. The pools used here titered 107.5 TCID~0 per 0.1 ml. 
Tissue C~Iture~.--Primaxy cultures of HEK and African green monkey kidney  (AGMK) 
were obtained from Flow Laboratories, Inc., Rockville, Md.  For fluorescent antibody (FA) 
tests,  cells were grown on cover slips in 50-mm Petri dishes (Falcon Plastics, Division of B-D 
Laboratories, Inc., Los Angeles, Calif.). Cells dispersed with trypsin-EDTA were seeded at a 
concentration of 400,000 cells per dish, and grown in 4 ml  of  Eagle's basal medium No.  2 
with penicillin, streptomycin, and glutamine (BME) with 10% unheated fetal bovine serum. 
Cultures were kept at 37°C  in  5%  CO2  atmosphere.  At  confluence,  cultures  were  rinsed 
twice with BME and renewed with 4  mi of maintenance medium consisting of 2% heated 
agammaglobuiinic calf serum in BME. Cultures were then inoculated with 0.1 ml of the ap- 
propriate virus dilution. At various times, cover slips were removed, rinsed, and fixed in cold 
acetone. 
Fluoresc~t Antibody Tests.--Tests  were done by the indirect method using antisera at a 
1 : 10 dilution. Horse anti-guinea pig (Progressive Laboratories, Baltimore, Md., lot No. 601) 
and goat anti-hamster (Baltimore Biologic Laboratories, lot RC-81) conjugates and rhodamine 
lissamine counterstain (5)  (obtained from Col. C. W. Smith) were used. The method for stain- 
ing FA tests has been described elsewhere (6). 
Adenovirus antigens were stained with guinea pig antiserum (3)  to E46-  (0); this serum 
(G.P. 35 Post)  showed high titered neutralizing antibody and had a  group specific reaction 
in FA and CF, indicating the presence of antibodies to fiber (C) and hexon (A) antigens. It 
did not stain T antigens. For convenience, the antigens stained with this serum will be referred 
to as Ad. 7 viral antigen. As described elsewhere (3), this serum did not react in CF or FA 
with, nor neutralize, any of the four AAV serotypes (3 and footnote 2). 
AAV-1 antigen was stained with the guinea pig antiserum (G. P.  14 Post) described pre- 
viously (3); it did not stain cultures infected with E46- (0) virus alone. It is inferred that the 
AAV-1 antigen stained by this serum is a  structural protein of the virion since staining was 
significantly reduced by mixture of the serum (diluted to contain 2 staining units) with purified 
AAV-1. 
Tests for Ad. 7 T  antigen were done with a serum prepared in two hamsters by foot pad 
inoculation with a mixture of Ad. 7 hamster tumor extract and Freund's complete adjuvant. 
This serum had a low CF antibody titer (1 : 10) against Ad. 7 tumor extract, and was negative 
against standard Ad. 7 viral antigen at a 1:10 serum dilution. It stained typical 5-fluorouracil 
deoxyriboside (FUDR)-resistant fleck-shaped antigen in cells infected with Ad. 7. 
The percentage of cells with specific staining was determined by counting 1000 to 4000 cells; 
for very low percentages, the number of positive cells on the entire cover slip was determined. 
Ultraviolet Irradiation Tests.--E46-  (0) was treated with UV light at 2537  A  by Dr.  C. 
Hiatt. Mean incident intensity (7)  was 8.6 ergs/mm  2 per sec for 175 sec (total dose of 1505 
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FUDR Inhibition Tests.--1 hr prior to virus inoculation, cultures were washed twice with 
BME and renewed with maintenance medium prepared with serum diaiysed against 0.85% 
NaC1 and containing 10  -e M  FUDR. For reversal of the FUDR effect, cells were washed five 
times with BME and renewed with standard medium enriched with 10  -e ~r thymidine. 
RESULTS 
General  Characteristics  of  AAV  [mmunofluorescent  Antigen.--HEK  cells 
infected with AAV alone showed no FA staining, but when infected with an 
adenovirus-AAV  mixture,  the  cells  readily produced  FA-stainable  antigen. 
As  will  be  shown  later,  AAV  immunofluorescent antigen  developed simul- 
taneously  with  adenovirus viral  antigen,  both  first  appearing  about  14-15 
hr after inoculation and reaching a plateau at 24-48 hr. The antigen was intra- 
nuclear and  of bright  intensity.  The nuclei were filled with uniform, finely 
granular material, usually without nucleolar sparing. Some positive ceils showed 
an accentuation of the nuclear membrane, while others had clumped aggre- 
gates of antigen in the nucleus, with thickened short strands  extending into 
the cytoplasm. Identical patterns were seen with AAV-1 antiserum prepared in 
hamsters, and the hamster antiserum blocked the FA staining by homotypic 
guinea pig antiserum. 
Information on the usefulness of the  FA  assay az a  tool for quantitative 
studies was obtained from dose-response assays using a varying dosage of AAV 
in the presence of a constant amount of adenovirus. Serial dilutions of heated 
AAV-1  were added  to HEK cultures simultaneously infected with 5  rD60 of 
FA6- (0)  per cell; replicate cover slips were fixed at  24  and  30 hr,  and  the 
percentage  of  FA-stainable  ceils  was  determined  with  AAV-1  guinea  pig 
serum. 
Fig.  1 shows results of a representative test. At both time points there was 
a  plateau  region until the  dosage of AAV fell below roughly one infectious 
particle per cell, after which the percentage of staining decreased in proportion 
to the dilution factor. The proportionality indicates that a single AAV particle 
is capable of initiating synthesis of antigen.  Comparison of the percentage of 
staining with the number of infectious AAV particles inoculated suggests that 
the FA assay is 1-1.5 loga0 less  sensitive than infectivity assays for virus de- 
tection, depending on time of harvest. 
The plateau region may be due to a  high  proportion of ceils  being either 
resistant to AAV or inadequately primed for AAV growth by adenovirus. 
The percentage of AAV staining obtained with a constant amount of AAV-1 
in the presence of varying dosages of Ad. 7 is shown in Table I. The dilution 
of AAV chosen was  on the falling portion of the AAV dose-response curve. 
With 10-100 TCID~0 of adenovirus per cell, about 16% of cells developed AAV 
antigen.  With  decreasing  dosage  of  adenovirus,  percentage  of  staining  de- 
creased at a rate compatible with one-hit kinetics. These findings indicate that 
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AAV,  and  that  the  incomplete  virus  particles  that  are  present  in  excess  in 
adenovirus preparations are unable to serve as helper agents. 
Inability of Abortive Adenovirus Infections  to Prime for AA V  Growth.--The 
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FIO. 1. Dose-response relationship of AAV-1 FA-stainable antigen in HEK cells. 
TABLE I 
Relation of Adenovirus Dosage to AA V Antigen 24 Hr after Infection wilk Both Viruses* 
E46-(0) m~o/Cell 
100 
10 
3 
1 
0.3 
0.1 
AAV staining 
% 
16.5 
15.5 
7.3 
1.7 
0.8 
0.05 
* All cultures were infected with 1 mso of AAV-1 per cell. 
majority of the present  studies were attempts  to determine  what stage of the 
adenovirus replicative  cycle must be reached before the cell is rendered  com- 
petent to synthesize AAV. Production of AAV antigen was taken  as the index 
of viral growth, since the antigen, like infectious virus, was not formed in cells 
without adenovirus helper. N. R. BLACKLOW,  M. D. HOGGAN~  AND  W. P. ROWE  759 
To determine if early events in the adenovirus cycle, as manifested by T 
antigen production, would suffice to permit AAV replication, we studied several 
systems in which there is a marked dissociation between T  and viral antigen 
induction. It has been reported previously (3)  that AAV did not replicate in 
cells of hamster tumors induced by Ad. 12, which contain large amounts of T 
antigen but little or no late viral proteins. 
Ad. 7 infection of many nonhuman cells produces an abortive infection with 
apparently normal T  antigen production but little or no viral  antigen. Mixed 
infection of dog kidney cells (MDCK cell line) with E46- (0)  and AAV-1 re- 
suited in formation of Ad. 7 T  antigen, but no AAV-1 or Ad. 7 viral antigen; 
it has been shown previously (3)  that AAV-1  does propagate in this cell line 
in the presence of canine hepatitis virus, an adenovirus which goes to comple- 
tion in these cells. 
TABLE  II 
Enhancement of AA V Antigen Production by SV40 +  Ad. 7 in AGMK 
Virus (3 mso/cell each) 
sv40 +  AAV 
Ad. 7 +  AAV 
SV40 +  Ad. 7 +  AAV 
Cells with FA-stainable antigen 
at 48 hr 
Ad.  7  T 
% 
0 
40 
45 
Ad.  TV 
% 
0 
0.08 
12.1 
AAV 
% 
0 
0.04 
9.6 
Monkey kidney cells similarly undergo abortive infection with Ad. 7; in this 
system it is known that the adenovirus infection progresses into the stage of 
DNA  synthesis (8),  and  that  the infection progresses  to  completion in  the 
presence  of  SV40  infection  (9).  Accordingly, AGMK  cells  were  inoculated 
with AAV-1, E46- (0),  and SV40 as a triple mixture and in various combina- 
tions (Table II). Again, the abortive adenovirus infection did not permit AAV 
replication, but the SV40 enhancement of adenovirus growth also resulted in 
enhancement  of AAV growth. 
Thus, these studies indicated that the event(s) in adenovirus growth neces- 
sary for enhancement of AAV occurs after T  antigen synthesis, and probably 
after viral DNA synthesis has begun. 
Time Course of AA V  and Ad.  7  Viral Antigen  Formation  in Sequentially 
Infected Cdls.--To obtain further information on the time at which the adeno- 
virus-infected cell becomes competent to replicate AAV,  we studied the time 
of appearance of AAV antigen in HEK cells receiving AAV at different times 
in relation to Ad. 7 (Fig. 2). In cells inoculated at the same time with AAV-1 
and E46- (0)  (Fig. 2 c), AAV antigen appeared simultaneously with the Ad. 7 76O  ADENOVIRUS-ASSOCIATED  VIRUS  AND  ADENOVIRUS  7 
viral antigen. Both antigens appeared at about 14 hr, that is, about  6 hr  after 
Ad. 7 T  antigen formation (10). Identical results were obtained in comparable 
tests with AAV-2  and AAV-3. 
In the experiments in which one virus was  inoculated prior to  the  other, 
the time of appearance of AAV antigen was determined by the time of Ad. 7 
inoculation. There was a minimum interval of 14--15 hr after adenovirus inocu- 
lation before appearance of AAV antigen,  which corresponded to the latent 
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FiG. 2. Time course  of development  of AAV-1 and Ad. 7 viral antigens in HEK cells. AAV-I 
and E46- (0) were  each used at multiplicities of I0 TCID~o  per cell. 
period of Ad. 7 viral antigen formation. In contrast, the latent period of AAV 
antigen formation in relation to time of AAV inoculation ranged from as long 
as 29 hr, when AAV was inoculated 15 hr before Ad. 7, to a minimum period 
of 5-6 hr, observed with Ad.  7 preinfection of 10 hr or more. Similar results 
were obtained in a comparable study with AAV-2. 
AAV infection did not significantly affect the time of Ad.  7 viral antigen 
formation (Fig.  2  c).  The slight inhibition of percent staining  in  the AAV- 
infected culture is presumably a  reflection of the previously described inhibi- 
tory effect of AAV on adenovirus yield (3). 
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viral antigen formation, and indicate that AAV has a latent period of 5-6 hr 
in a competent cell. That this minimum latent period was reached with Ad. 7 
preinfection of 10 hr suggests that the adenovirus-infected cell becomes compe- 
tent for AAV synthesis at  the  10th hr or later,  confirming that the  crucial 
event(s) occurs late in the adenovirus cycle. On the basis of this finding,  the 
10 hr Ad.  7 preinfection period was  used in most of the subsequent experi- 
ments; it was felt that this might minimize any effects of AAV on its adeno- 
virus helper. 
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FIG. 3. Effect of ultraviolet irradiation of E46- (0) on the development  of AAV-1 and Ad. 
7 antigens. 
Another  indication of a  close relationship  between AAV  and Ad.  7  viral 
antigen  formation came  from experiments with  UV-irradiated  Ad.  7  as  the 
helper.  Previous studies  ~ have  shown  that  UV-irradiated  Ad.  7  produces T 
antigen slightly later than the normal 6-8 hr latent period, but produces viral 
antigen  much  later  than  does  unirradiated  virus.  This prolongation is  pre- 
sumably the result of delay of viral DNA synthesis until repair processes allow 
it to proceed. Time curve studies were done of Ad. 7 and AAV antigen forma- 
tion in HEK cells receiving irradiated or nonirradiated FA6- (0) as the helper. 
The UV irradiation was carried out as described in Materials and Methods. The 
Rowe, W. P., S. G. Baum, and C. W. HJatt. Unpublished data. 762  ADENOVIRUS-ASSOCIATED  VIRUS  AND  ADENOVIRUS  7 
unirradiated E46-(0)  was inoculated onto HEK  cells  at  a  multiplicity of 3 
TCIDs0 per cell, and the irradiated sample was used at the same dilution. At 
10 hr, AAV-1 (unirradiated) was added to both sets of cultures at a multiplicity 
of 3 TCIDs0 per cell, together with Ad. ? guinea pig antiserum (final concentra- 
tion 1%)  to prevent second cycle infection. The results are shown in Fig. 3. 
Again AAV antigen appeared simultaneously with the Ad. 7 viral antigen, even 
though there was about a 23 hr delay in the formation of the viral antigen with 
the UV-treated Ad. 7. 
Attempt to Dissociate AA V and Ad. 7 Viral Antigen Production by Temporary 
Inhibition with FUDR.--The close temporal association between formation of 
AAV and Ad. 7 viral antigens suggested that the crucial event(s) in adenovirus 
replication may occur immediately  before formation of adenovirus viral antigen. 
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F1o. 4. Dissociation of AAV-1 and Ad. 7 viral antigens by temporary inhibition with 
FUDR. AAV-1 and E46- (0) were each used at multiplicities  of 10 TCIDs0 per cell. 
This possibility could be minimized only if a system could be found in which 
AAV antigen formed significantly earlier than the adenovirus antigen. Some 
success  in obtaining this result was achieved with FUDR inhibition studies. 
FUDR treatment of human cells infected with adenoviruses does not affect T 
antigen formation, but blocks viral  DNA  synthesis and formation of viral 
antigens (10-13); this inhibition can be reversed by thymidine. AAV growth is 
also blocked by FUDR, probably because of the effect on both the Ad. 7 and 
AAV DNA replication. However, the possibility existed that in an FUDR in- 
hibited cycle, the early events of AAV growth might proceed far enough that 
on reversal of the FUDR effect, the intrinsically shorter AAV growth cycle 
might proceed to completion earlier than that of the adenovirus helper. 
HEK cells were placed in medium containing FUDR, and 1 hr later infected 
with E46-  (0).  AAV-1  was added  10  hr later  (11  hr  after first exposure  to 
FUDR).  4  hr  later,  during  which  time  AAV  presumably underwent early N. R. BLACKLOW,  M. D. HOGGAN,  AND  W. P. ROWE  763 
FUDR-resistant stages of its cycle, the FUDR inhibition was reversed with 
thymidine.  Cover  slips were harvested  at various  times,  with results  as  in 
Fig. 4. In both experiments the AAV antigen appeared 3 hr earlier than the 
Ad.  7  antigen  after  FUDR  reversal,  while in  the  control  cultures  without 
FUDR the two antigens formed together. Thus it is possible to obtain AAV 
antigen formation significantly earlier than the terminal events in Ad. 7 viral 
antigen formation. Parallel cultures in which the FUDR inhibition was not 
reversed showed no AAV or Ad. 7 viral  antigen staining at 26 hr after AAV 
inoculation. 
In a  similar experiment in which AAV was added at  the time of FUDR 
reversal, the AAV antigen formed simultaneously with the Ad. 7 viral antigen, 
beginning at 5 hr.  This confirmed that in the experiments shown in Fig. 4  the 
AAV underwent early repllcative processes during the period of FUDR  in- 
hibition. 
DISCUSSION 
The studies reported here suggest that the critical event in the adenovirus 
cycle required for AAV growth is associated with replication of the adenovirus 
DNA. First, a variety of observations indicated that the pre-DNA-replicative 
antigens do not suffice  to render the cell competent.  Second,  the sequential 
inoculation studies indicated that the decisive event occurred after the 10th hr. 
Third,  the FUDR reversal experiments, in which AAV antigen formed 3 hr 
before Ad.  7 viral antigen, showed that the critical event is not a  terminal 
stage in adenovirus viral antigen formation, but probably occurs appreciably 
earlier. Thus,  the event may well occur during the 10th-12th hr, which has 
been shown to be the period of active adenovirus DNA synthesis (II, 12,  14, 
15). 
The simultaneity of formation of the AAV  and Ad. 7 viral  antigens under a 
variety  of  experimental  conditions was  striking, and  suggested  either 
that AAV  antigen formation required a very late  step  in the adcnovirus cycle, 
or that synthesis of the two antigens was subject to a common  rate-limiting 
process. The FUDR  reversal experiment indicated that the latter was the 
case.  It further  indicated that during the period of FUDR  ~nMbition, the AAV 
cycle  or the formation of an essential  adenovirus product proceeded far enough 
that the progression of AAV  replication  after FUDR  reversal  was no longer 
subject to the rate-limiting  process. 
Although adenovirus DNA  synthesis  may well  be required for AAV  growth, 
the studies  in  monkey cells  suggested that the adenovirus DNA  synthesis  is  not 
in itself  sufl~dent to render a cell  competent for AAV  growth. Ad. 7 infection 
of these  cells  results  in production of new viral  DNA  with relatively  high eCfi- 
ciency (8),  but without SV40 enhancement the late  viral  antigens do not form, 
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The ability to use AAV as a separate component added at a  different time 
in relation to adenovirus is of practical value in studying the factors that influ- 
ence the two components of this system. In particular, adenovirus preinfection 
has provided the basis for developing a neutralization test  4 for AAV antibody, 
without the complication of antibody to the adenovirus helper giving a false 
positive  neutralization. 
SUMMARY 
A  quantitative immunofluorescent procedure for detection of viral antigen 
was used to study the potentiation of AAV-1 by Ad. 7. AAV viral antigen formed 
only when the cells were also infected with adenovirus, and only in cell culture 
systems  in  which the  adenovirus  infection proceeded  to  completion.  Ad.  7 
infection of AGMK cell cultures did not potentiate AAV  unless  the  Ad.  7 
infection was itself potentiated by SV40.  Dose-response studies indicated that 
a single AAV particle and a single  infectious Ad. 7 particle sufficed to initiate 
AAV antigen synthesis. 
Sequential inoculation studies showed that AAV antigen formed simultane- 
ously with Ad. 7 viral antigen when the AAV was inoculated any time between 
15 hr before to 10 hr after the Ad. 7, both antigens appearing about 15 hr after 
inoculation of Ad.  7.  The AAV-1 antigen  formation had a  minimum  latent 
period of 5 hr,  as seen with Ad.  7 preinfection of 10 hr or more. When UV- 
irradiated Ad. 7 was used as helper, the AAV antigen still appeared simultane- 
ously with the Ad.  7 viral antigen,  even though the latter was delayed by 23 
hr compared to nonirradiated virus. 
When the early replicative events of both viruses were allowed to proceed in 
FIYDR-inhibited cells,  and then the FUDR inhibition was reversed, AAV anti- 
gen formed within 2 hr, which was 3 hr before the Ad. 7 viral antigen appeared. 
It was inferred that  the event in the adenovirus cycle that renders a  cell 
competent to synthesize AAV occurs after the 10th hr and may be temporally 
associated with replication of the adenovirus DNA. 
We wish to thank Doctors James A. Rose and Sherman M. Weissman for reviewing this 
manuscript. We are indebted to Mrs. Patricia H. Laine for her valuble technical assistance. 
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